151 related articles for article (PubMed ID: 26756274)
1. Addressing issues associated with evaluating prediction models for survival endpoints based on the concordance statistic.
Wang M; Long Q
Biometrics; 2016 Sep; 72(3):897-906. PubMed ID: 26756274
[TBL] [Abstract][Full Text] [Related]
2. Assessing predictive accuracy of survival regressions subject to nonindependent censoring.
Wang M; Long Q; Chen C; Zhang L
Stat Med; 2020 Feb; 39(4):469-480. PubMed ID: 31814158
[TBL] [Abstract][Full Text] [Related]
3. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.
Dong G; Mao L; Huang B; Gamalo-Siebers M; Wang J; Yu G; Hoaglin DC
J Biopharm Stat; 2020 Sep; 30(5):882-899. PubMed ID: 32552451
[TBL] [Abstract][Full Text] [Related]
4. Concordance indices with left-truncated and right-censored data.
Hartman N; Kim S; He K; Kalbfleisch JD
Biometrics; 2023 Sep; 79(3):1624-1634. PubMed ID: 35775234
[TBL] [Abstract][Full Text] [Related]
5. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
Latimer NR; Abrams KR; Siebert U
BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
[TBL] [Abstract][Full Text] [Related]
6. Concordance for prognostic models with competing risks.
Wolbers M; Blanche P; Koller MT; Witteman JC; Gerds TA
Biostatistics; 2014 Jul; 15(3):526-39. PubMed ID: 24493091
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
O'Brien MF; Cronin AM; Fearn PA; Smith B; Stasi J; Guillonneau B; Scardino PT; Eastham JA; Vickers AJ; Lilja H
J Clin Oncol; 2009 Aug; 27(22):3591-7. PubMed ID: 19506163
[TBL] [Abstract][Full Text] [Related]
8. Machine learning for survival analysis: a case study on recurrence of prostate cancer.
Zupan B; Demsar J; Kattan MW; Beck JR; Bratko I
Artif Intell Med; 2000 Aug; 20(1):59-75. PubMed ID: 11185421
[TBL] [Abstract][Full Text] [Related]
9. Model selection for survival individualized treatment rules using the jackknife estimator.
Honvoh GD; Cho H; Kosorok MR
BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
[TBL] [Abstract][Full Text] [Related]
10. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy nomograms in black American men: accuracy and applicability.
Bianco FJ; Kattan MW; Scardino PT; Powell IJ; Pontes JE; Wood DP
J Urol; 2003 Jul; 170(1):73-6; discussion 76-7. PubMed ID: 12796648
[TBL] [Abstract][Full Text] [Related]
12. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
Willems S; Schat A; van Noorden MS; Fiocco M
Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
[TBL] [Abstract][Full Text] [Related]
13. On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects.
Blanche PF; Holt A; Scheike T
Lifetime Data Anal; 2023 Apr; 29(2):441-482. PubMed ID: 35799026
[TBL] [Abstract][Full Text] [Related]
14. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
[TBL] [Abstract][Full Text] [Related]
15. Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models.
Boehm K; Larcher A; Beyer B; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Heinzer H; Graefen M; Budäus L
Eur Urol; 2016 Jun; 69(6):1038-43. PubMed ID: 26272236
[TBL] [Abstract][Full Text] [Related]
16. Estimating the concordance probability in a survival analysis with a discrete number of risk groups.
Heller G; Mo Q
Lifetime Data Anal; 2016 Apr; 22(2):263-79. PubMed ID: 26022558
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, Predictive Factors, and Prediction Nomograms for
Rauscher I; Düwel C; Haller B; Rischpler C; Heck MM; Gschwend JE; Schwaiger M; Maurer T; Eiber M
Eur Urol; 2018 May; 73(5):656-661. PubMed ID: 29358059
[TBL] [Abstract][Full Text] [Related]
18. Generalized pairwise comparisons for censored data: An overview.
Deltuvaite-Thomas V; Verbeeck J; Burzykowski T; Buyse M; Tournigand C; Molenberghs G; Thas O
Biom J; 2023 Feb; 65(2):e2100354. PubMed ID: 36127290
[TBL] [Abstract][Full Text] [Related]
19. Prioritized concordance index for hierarchical survival outcomes.
Cheung LC; Pan Q; Hyun N; Katki HA
Stat Med; 2019 Jul; 38(15):2868-2882. PubMed ID: 30957257
[TBL] [Abstract][Full Text] [Related]
20. Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring.
Chakladar S; Rosin S; Hudgens MG; Halloran ME; Clemens JD; Ali M; Emch ME
Biometrics; 2022 Jun; 78(2):777-788. PubMed ID: 33768557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
